Key takeaways
Farxiga (dapagliflozin) and Rybelsus (semaglutide) are used to treat Type 2 diabetes, but there are several differences between the two medications. Farxiga helps lower blood sugar by removing excess sugar through urine. It also helps reduce the risk of heart failure and chronic kidney disease complications. On the other hand, Rybelsus lowers blood sugar by increasing insulin release, reducing sugar production in the liver, and slowing digestion. Unlike Farxiga, Rybelsus has a warning for potentially causing thyroid tumors or cancer. Farxiga can cause dehydration and urinary tract infections, while Rybelsus commonly causes nausea, vomiting, and diarrhea. Both medications are brand-name only and are taken orally, but Rybelsus must be taken on an empty stomach first thing in the morning.
